The third-generation leader of CFR Pharmaceuticals had been victorious in carrying out a strategy of merging pharmaceutical companies across Latin America. As section of the expansion strategy of the company's, opportunities were investigated by the CEO enlarge CFR Pharmaceutical's footprint in emerging markets and to develop multiple sources of increase; to do this, he found a business in South Africa, Adcock Ingram, to acquire. The combined firm would offer CFR merchandise synergy and diversification, improved distribution and manufacturing abilities as well as an exceptional emerging marketplace footprint in 23 countries.
In the method of making an offer of around US$1.2 billion to get the firm, the CEO faced increased interest in Adcock from other prospective acquirers. CFR kept the consistent support of the Adcock Ingram board, although he also ran into a succession of issues when the acquisition was resisted by an Adcock investor.
PUBLICATION DATE: December 01, 2014 PRODUCT #: W14589-HCB-ENG
This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE
Related Case Solutions & Analyses:
Frontgate Catalog
A-CAT Corp.: Forecasting
IBM and the Reinvention of High School (B): Replicating & Scaling P-TECH and Partners
Nurturing Green: The Growth Dilemma (C)
Canadian National Railway Company: Culture Change (A)
Kapco Limited (C) – Matt Gruber
SoJo: Modeling Social Enterprise
Clarence Hall University and the Donation
The Night Ministry: Facing the Loss of a Founder
GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships
